丁香TP1 保护低氧诱导的功能障碍和ER压力相关的亡
Bamaprasad Dutta1, Shining Loo1,2, Antony Kam1,3
1School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
Cells
|July 6, 2023
概括
人参中的一种化合物 - - 人参TP1保护人体内皮细胞免受缺氧和ER压力. 这种微蛋白减轻了血管内皮功能障碍,为心血管疾病提供了潜在的新疗法.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 缺氧诱导的血管内皮功能障碍 (VED) 导致诸如心脏病和中风等严重疾病.
- 目前的VED治疗受限于对疾病机制的理解不足.
- 人参含有人参TP1,一种微蛋白,在心血管模型中显示出有前途.
研究的目的:
- 确定在低氧期间合成的蛋白质.
- 调查人参TP1对内皮细胞的保护作用,防止缺氧和ER压力.
- 阐明VED和人参胺TP1的治疗作用的机制.
主要方法:
- 功能性测试是指功能性测试.
- 定量脉冲SILAC蛋白质组学 定量脉冲SILAC蛋白质组学
- 在低氧和ER压力条件下的内皮细胞培养.
主要成果:
- 缺氧激活了导致内皮激活,单细胞粘附,氧化物 (NO) 信号受损和氧化应激的途径.
- 缺氧触发了内细胞网膜 (ER) 的压力和亡途径.
- 锦胺TP1治疗减少了粘附分子表达,白细胞粘附,ER应激和氧化应激,同时恢复了NO的生物利用性和保护细胞死亡.
结论:
- 丁香TP1有效地减轻缺氧诱导的血管内皮功能障碍.
- 这种微蛋白可能是人参治疗效果中的关键生物活性化合物.
- 研究结果表明,有可能开发基于人参TP1.1.的新型心血管疾病疗法.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
202
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
202
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


